跳至主要内容
临床试验/NCT04974515
NCT04974515已完成不适用

Adherence to Electrical Glossal In Situ Stimulation for Sleep Apnea

University of Miami2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年8月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Mean Number of Days Device Was Used

研究概览

简要总结

The purpose of this research is to assess how well people with mild obstructive sleep apnea (OSA) adhere to the eXciteOSA device and specifically examine whether adherence of the device is different with low versus high electrical stimulation. In addition, this research study will assess how well the device affects mild sleep apnea and if it improves sleepiness and quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than 18 years
  • Ability to consent
  • Home sleep apnea test demonstrating mild obstructive sleep apnea.
  • Smartphone or tablet

排除标准

  • Current pacemaker, defibrillator, or neuro-stimulation device
  • No prior oropharyngeal surgery for sleep apnea
  • No implants, metal prostheses, dental braces, or soft tissue/bony ulcerations in the oral cavity
  • No prior use of mandibular advancement device (MAD) or continuous positive airway pressure (CPAP)
  • Heart failure (New York Heart Association Class 3 or 4; or ejection fraction < 45%)
  • Active coronary disease defined as an intervention (e.g., angioplasty, coronary artery bypass surgery) in the prior 6 months
  • Uncontrolled hypertension (BP > 160/100)
  • Clinician diagnosis of any chronic lung disease except asthma
  • Chronic fatigue syndrome or fibromyalgia
  • Self-reported current illicit drug use in the past 30 days
  • Self-reported use of marijuana or opiates in the past 30 days
  • Use of supplemental oxygen
  • Self-reported use of prescribed or over the counter sleeping medications in the past 30 days
  • Current pregnancy or intention of becoming pregnant
  • Oropharyngeal abnormalities (class 2 or class 3 malocclusion)
  • Periodic breathing (Cheyne Stoke respiration)
  • Central sleep apnea (central apnea index (CAI) > 5/h)
  • Investigator discretion

结局指标

主要结局

Mean Number of Days Device Was Used

时间窗: Up to 6 weeks

Adherence level will be reported as the mean number of days the eXciteOSA device was used.

次要结局

  • Work Productivity and Activity Impairment (WPAI) Questionnaire Scores(Up to 6 weeks)
  • Snoring Visual Analog Scores(Up to 6 weeks)
  • Epworth Sleepiness Scale (ESS) Scores(Up to 6 weeks)
  • Quality of Life as Measured by EuroQol Score(Up to 6 weeks)
  • Number of Participants Accepting Long Term Treatment(6 weeks)
  • Mean Respiratory Event Index (REI)(Up to 6 weeks)
  • Pittsburgh Sleep Quality Index (PSQI)(Up to 6 weeks)
  • Short Form-20 (SF-20) Scores(Up to 6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Naresh Punjabi

Professor of Clinical

University of Miami

研究点 (2)

Loading locations...

相似试验